Literature DB >> 28349230

The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients.

Ahmad Baseer Kaihan1, Yoshinari Yasuda2, Takayuki Katsuno1, Sawako Kato1, Takahiro Imaizumi1, Takaya Ozeki1, Manabu Hishida1, Takanobu Nagata1, Masahiko Ando1, Naotake Tsuboi1, Shoichi Maruyama1.   

Abstract

BACKGROUND: The Oxford Classification is utilized globally, but has not been fully validated. In this study, we conducted a comparative analysis between the Oxford Classification and Japanese Histologic Classification (JHC) to predict renal outcome in Japanese patients with IgA nephropathy (IgAN).
METHODS: A retrospective cohort study including 86 adult IgAN patients was conducted. The Oxford Classification and the JHC were evaluated by 7 independent specialists. The JHC, MEST score in the Oxford Classification, and crescents were analyzed in association with renal outcome, defined as a 50% increase in serum creatinine.
RESULTS: In multivariate analysis without the JHC, only the T score was significantly associated with renal outcome. While, a significant association was revealed only in the JHC on multivariate analysis with JHC.
CONCLUSIONS: The JHC and T score in the Oxford Classification were associated with renal outcome among Japanese patients with IgAN. Superiority of the JHC as a predictive index should be validated with larger study population and cohort studies in different ethnicities.

Entities:  

Keywords:  ESRD; IgA nephropathy; Japanese Histologic Classification; Oxford Classification; Renal pathology

Mesh:

Year:  2017        PMID: 28349230     DOI: 10.1007/s10157-017-1393-x

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  46 in total

1.  Schönlein-Henoch nephritis.

Authors:  S R Meadow; E F Glasgow; R H White; M W Moncrieff; J S Cameron; C S Ogg
Journal:  Q J Med       Date:  1972-07

2.  Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses.

Authors:  E Alamartine; J C Sabatier; C Guerin; J M Berliet; F Berthoux
Journal:  Am J Kidney Dis       Date:  1991-07       Impact factor: 8.860

3.  The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.

Authors:  J V Donadio; J P Grande; E J Bergstralh; R A Dart; T S Larson; D C Spencer
Journal:  J Am Soc Nephrol       Date:  1999-08       Impact factor: 10.121

4.  Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.

Authors:  Ryota Ikee; Shuzo Kobayashi; Takamitsu Saigusa; Tamehachi Namikoshi; Muneharu Yamada; Noriaki Hemmi; Toshihiko Imakiire; Yuichi Kikuchi; Shigenobu Suzuki; Soichiro Miura
Journal:  Hypertens Res       Date:  2006-01       Impact factor: 3.872

5.  Histopathologic features aid in predicting risk for progression of IgA nephropathy.

Authors:  Michael Walsh; Aylin Sar; Diane Lee; Serdar Yilmaz; Hallgrimur Benediktsson; Braden Manns; Brenda Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

6.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Authors:  Ian S D Roberts; H Terence Cook; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Daniel C Cattran; Rosanna Coppo; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; John Feehally; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

7.  IgA nephropathy: morphologic predictors of progressive renal disease.

Authors:  S M Lee; V M Rao; W A Franklin; M S Schiffer; A J Aronson; B H Spargo; A I Katz
Journal:  Hum Pathol       Date:  1982-04       Impact factor: 3.466

8.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

9.  Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.

Authors:  Weibo Le; Cai-Hong Zeng; Zhangsuo Liu; Dong Liu; Qing Yang; Rui-Xia Lin; Zheng-Kun Xia; Zhong-Min Fan; Guanghua Zhu; Ying Wu; Hong Xu; Yihui Zhai; Ying Ding; Xiaoqing Yang; Shaoshan Liang; Hao Chen; Feng Xu; Qian Huang; Hongbing Shen; Jianming Wang; Agnes B Fogo; Zhi-Hong Liu
Journal:  BMC Nephrol       Date:  2012-11-27       Impact factor: 2.388

10.  Long-term prognosis of clinically early IgA nephropathy is not always favorable.

Authors:  Hajeong Lee; Jin Ho Hwang; Jin Ho Paik; Hyun Jin Ryu; Dong Ki Kim; Ho Jun Chin; Yun Kyu Oh; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee
Journal:  BMC Nephrol       Date:  2014-06-19       Impact factor: 2.388

View more
  5 in total

1.  Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy.

Authors:  Yusuke Fukao; Hitoshi Suzuki; Jin Sug Kim; Kyung Hwan Jeong; Yuko Makita; Toshiki Kano; Yoshihito Nihei; Maiko Nakayama; Mingfeng Lee; Rina Kato; Jer-Ming Chang; Sang Ho Lee; Yusuke Suzuki
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

2.  Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission.

Authors:  Koji Inagaki; Yoshinari Yasuda; Masahiko Ando; Ahmad Baseer Kaihan; Asaka Hachiya; Takaya Ozeki; Manabu Hishida; Takahiro Imaizumi; Takayuki Katsuno; Sawako Kato; Naotake Tsuboi; Shoichi Maruyama
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

3.  Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Schönlein purpura nephritis: a multicenter retrospective cohort study.

Authors:  Koji Inagaki; Ahmad Baseer Kaihan; Asaka Hachiya; Takaya Ozeki; Masahiko Ando; Sawako Kato; Yoshinari Yasuda; Shoichi Maruyama
Journal:  BMC Nephrol       Date:  2018-08-17       Impact factor: 2.388

4.  Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients.

Authors:  Ahmad Baseer Kaihan; Yoshinari Yasuda; Takahiro Imaizumi; Koji Inagaki; Takaya Ozeki; Manabu Hishida; Takayuki Katsuno; Naotake Tsuboi; Shoichi Maruyama
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240

Review 5.  Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?

Authors:  Bogdan Obrișcă; Ioanel Sinescu; Gener Ismail; Gabriel Mircescu
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.